Holly Symolon

879 total citations
6 papers, 711 citations indexed

About

Holly Symolon is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Holly Symolon has authored 6 papers receiving a total of 711 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 1 paper in Oncology and 1 paper in Pharmacology. Recurrent topics in Holly Symolon's work include Sphingolipid Metabolism and Signaling (6 papers), Lipid Membrane Structure and Behavior (2 papers) and Protein Kinase Regulation and GTPase Signaling (1 paper). Holly Symolon is often cited by papers focused on Sphingolipid Metabolism and Signaling (6 papers), Lipid Membrane Structure and Behavior (2 papers) and Protein Kinase Regulation and GTPase Signaling (1 paper). Holly Symolon collaborates with scholars based in United States. Holly Symolon's co-authors include Alfred H. Merrill, Jeremy C. Allegood, Elaine Wang, Samuel Kelly, Myles C. Cabot, Qiong Peng, Harsha Ramaraju, M. Cameron Sullards, Wenjing Zheng and Amin A. Momin and has published in prestigious journals such as The FASEB Journal, Journal of Nutrition and Biochimica et Biophysica Acta (BBA) - Biomembranes.

In The Last Decade

Holly Symolon

6 papers receiving 702 citations

Peers

Countries citing papers authored by Holly Symolon

Since Specialization

Citations

This map shows the geographic impact of Holly Symolon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Holly Symolon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Holly Symolon more than expected).

Fields of papers citing papers by Holly Symolon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Holly Symolon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Holly Symolon. The network helps show where Holly Symolon may publish in the future.

Co-authorship network of co-authors of Holly Symolon

This figure shows the co-authorship network connecting the top 25 collaborators of Holly Symolon. A scholar is included among the top collaborators of Holly Symolon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Holly Symolon. Holly Symolon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

#	Work	Indexed citations
1	Enigmol: A Novel Sphingolipid Analogue with Anticancer Activity against Cancer Cell Lines and In vivo Models for Intestinal and Prostate Cancer 2011 ·Molecular Cancer Therapeutics ·Holly Symolon, Anatoliy Bushnev, Qiong Peng, Harsha Ramaraju, (unknown), Jeremy C. Allegood, Sarah T. Pruett, M. Cameron Sullards, Dirck L. Dillehay, Dennis C. Liotta, Alfred H. Merrill	52
2	N-(4-Hydroxyphenyl)retinamide increases dihydroceramide and synergizes with dimethylsphingosine to enhance cancer cell killing 2008 ·Molecular Cancer Therapeutics ·Hongtao Wang, Barry J. Maurer, Yu Liu, Elaine Wang, Jeremy C. Allegood, Samuel Kelly, Holly Symolon, Ying Liu, Alfred H. Merrill, Valérie Gouazé‐Andersson, Jing Yu, Armando E. Giuliano, Myles C. Cabot	90
3	Safingol Toxicology After Oral Administration to TRAMP Mice: Demonstration of Safingol Uptake and Metabolism by N-Acylation and N-Methylation 2007 ·Drug and Chemical Toxicology ·Pablo Morales, Dirck L. Dillehay, (unknown), David C. Pallas, Sarah T. Pruett, (unknown), Holly Symolon, Alfred H. Merrill	17
4	Fenretinide induces lethal autophagy via a novel ensemble of life and death regulators: dihydroceramide and sphinganine versus sphinganine 1‐phosphate. 2007 ·The FASEB Journal ·(unknown), (unknown), Holly Symolon, Wenjing Zheng, (unknown), Amin A. Momin, (unknown), (unknown), Samuel Kelly, Jeremy C. Allegood, Elaine Wang, Alfred H. Merrill	1
5	Ceramides and other bioactive sphingolipid backbones in health and disease: Lipidomic analysis, metabolism and roles in membrane structure, dynamics, signaling and autophagy 2006 ·Biochimica et Biophysica Acta (BBA) - Biomembranes ·Wenjing Zheng, (unknown), Holly Symolon, Amin A. Momin, (unknown), Elaine Wang, Samuel Kelly, Jeremy C. Allegood, Ying Liu, Qiong Peng, Harsha Ramaraju, M. Cameron Sullards, Myles C. Cabot, Alfred H. Merrill	453
6	Dietary Soy Sphingolipids Suppress Tumorigenesis and Gene Expression in 1,2-Dimethylhydrazine-Treated CF1 Mice and Apc/+ Mice 2004 ·Journal of Nutrition ·Holly Symolon, Eva M. Schmelz, Dirck L. Dillehay, Alfred H. Merrill	98

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact